Sagiment Biosciences Stock Quote SGMT - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

4.06

Bid

4.07

Ask

4.20

Volume

325,272

3.88 Day's Range 4.15

2.13 52 Week Range 20.71

Market Cap

86.998M

Previous Close

3.92

Open

4.00

Last Trade

4.07

Last Trade Time

Financial Volume

$ 1,312,153

VWAP

4.034

Average Volume (3m)

1,029,570

Shares Outstanding

21,375,402

Dividend Yield

PE Ratio

-3.12

Earnings Per Share (EPS)

-1.3

Revenue

Net Profit

-27.88M

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment ... Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Camden, Delaware, USA

Founded

1970

Sagiment Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SGMT. The last closing price for Sagiment Biosciences was $3.92. Over the last year, Sagiment Biosciences shares have traded in a share price range of $ 2.13 to $ 20.71.

Sagiment Biosciences currently has 21,375,402 shares outstanding. The market capitalization of Sagiment Biosciences is $87 million. Sagiment Biosciences has a price to earnings ratio (PE ratio) of -3.12.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.15	3.83631713555	3.91	4.31	3.83	308257	4.08667206	CS
4	-1.57	-27.8863232682	5.63	5.825	3.83	432414	4.84392225	CS
12	-6.29	-60.7729468599	10.35	11.03	3.83	1029570	6.01987307	CS
26	-0.1	-2.40384615385	4.16	20.71	2.13	973690	10.42223331	CS
52	-11.44	-73.8064516129	15.5	20.71	2.13	667212	10.53797884	CS
156	-11.44	-73.8064516129	15.5	20.71	2.13	667212	10.53797884	CS
260	-11.44	-73.8064516129	15.5	20.71	2.13	667212	10.53797884	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M